Resolution of tardive dyskinesia after addition of aripiprazole to haloperidol depot [9]

Journal of Clinical Psychopharmacology

Volumn 27, Issue 5, 2007, Pages 525-526

  Kantrowitz, Joshua T ^a,b   Srihari, Vinod H ^b   Tek, Cenk ^b  

^a NATHAN S KLINE INSTITUTE FOR PSYCHIATRIC RESEARCH   (United States)

^b YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARIPIPRAZOLE; COCAINE; HALOPERIDOL DECANOATE; QUETIAPINE;

ADULT; ANAMNESIS; AUDITORY HALLUCINATION; CASE REPORT; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; DRUG DOSE INCREASE; DRUG SUBSTITUTION; DRUG WITHDRAWAL; FOLLOW UP; HUMAN; LETTER; MALE; MEDICAL RECORD; PRIORITY JOURNAL; RISK ASSESSMENT; SCORING SYSTEM; TARDIVE DYSKINESIA;

ANTIPSYCHOTIC AGENTS; DELAYED-ACTION PREPARATIONS; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG THERAPY, COMBINATION; DYSKINESIA, DRUG-INDUCED; HALOPERIDOL; HUMANS; MALE; MIDDLE AGED; PIPERAZINES; QUINOLONES; REMISSION INDUCTION; SCHIZOPHRENIA; SUBSTANCE-RELATED DISORDERS;

EID: 34548685004     PISSN: 02710749     EISSN: None     Source Type: Journal    
DOI: 10.1097/JCP.0b013e31814f3002     Document Type: Letter

References (8)

1. Duggal HS. Aripiprazole-induced improvement in tardive dyskinesia. Can J Psychiatry. 2003;48:771-772.
2. Grant MJ, Baldessarini RJ. Possible improvement of neuroleptic-associated tardive dyskinesia during treatment with aripiprazole. Ann Pharmacother. 2005;39:1953.
3. Sharma A, Ramaswamy S, Dewan VK. Resolution of ziprasidone-related tardive dyskinesia with a switch to aripiprazole. Prim Care Companion J Clin Psychiatry. 2005;7:36.
4. Witschy JK, Winter AS. Improvement in tardive dyskinesia with aripiprazole use. Can J Psychiatry. 2005;50:188.
5. Miller DD, Kim E, Eudicone J, et al. Incidence and severity of tardive dyskinesia in patients receiving aripiprazole or haloperidol for the treatment of schizophrenia or schizoaffective disorder. ACNP Conference abstracts. Presented at the Poster Session at the American College of Neuropsychopharmacology, 45th Annual Meeting in Hollywood, Florida at the Westin Diplomat, December 4, 2006.
6. Farah A. Resolution of tardive dyskinesia with quetiapine. Schizophr Res. 2001;47:309-310.
7. Diederich NJ, Goetz CG. Drug-induced movement disorders. Neurol Clin. 1998;16:125-139.
8. Gupta S, Masand P. Aripiprazole: review of its pharmacology and therapeutic use in psychiatric disorders. Ann Clin Psychiatry. 2004;16: 155-166.